At last count, the Food and Drug Administration has authorized 950 medical devices that use artificial intelligence and machine learning. But far fewer have made a significant impact on patient care in the United States.
For medical AI developers like James Zou, that’s a problem. The Stanford professor is invested in getting effective medical machine learning — including some of his own, FDA-cleared algorithms — adopted by health systems.
In two recent papers, Zou examined the clinical adoption of medical AI devices, finding that a tiny minority of FDA-authorized devices are being reimbursed at any kind of scale — and delving into different models for how health systems could pay for medical AI.
Click this link for the original source of this article.
Author: Katie Palmer
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
